Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt

J Egypt Public Health Assoc. 2024 Dec 4;99(1):32. doi: 10.1186/s42506-024-00178-4.

Ahmad N Fasseeh^{1

2}, Nada Korra³, Baher Elezbawy², Amal S Sedrak^{4

5}, Mary Gamal⁵, Randa Eldessouki⁶, Mariam Eldebeiky⁵, Mohsen George⁷, Ahmed Seyam⁷, Asmaa Abourawash⁸, Ahmed Y Khalifa⁹, Mayada Shaheen¹⁰, Sherif Abaza², Zoltán Kaló^{11

12}

¹ Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Syreon Middle East, Alexandria, Egypt.
³ Syreon Middle East, Alexandria, Egypt. [email protected].
⁴ Department of Public Health, Cairo University, Cairo, Egypt.
⁵ Egyptian Authority for Unifed Procurement, Medical Supply and Technology Management, Cairo, Egypt.
⁶ Department of Community Health, Fayoum University, Fayoum, Egypt.
⁷ Universal Health Insurance Authority, Cairo, Egypt.
⁸ Egyptian Drug Authority, Cairo, Egypt.
⁹ World Health Organization Representative Office, Cairo, Egypt.
¹⁰ Roche, Cairo, Egypt.
¹¹ Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
¹² Syreon Research Institute, Budapest, Hungary.

No abstract available

Publication types